Board certified in psychiatry and addiction psychiatry by the American Board of Psychiatry and Neurology, Dr. Iannucci is an instructor in psychiatry at Harvard Medical School. His clinical interests include treatment of people with severe substance use disorders and those with co-occurring mental health conditions. He has published on the treatment of addiction in residential programs, and on cocaine abuse.
McLean Signature Recovery Programs: FernsideADD YOUR REVIEW
Paying for Treatment
- Insurance is not Accepted
- Financing is not Available
- Medicare is not Accepted
- Medicaid is not Accepted
Harvard Medical School-affiliated McLean Fernside specializes in residential treatment plans that address the primary addiction as well as accompanying co-occurring psychiatric disorders. As part of our Signature Recovery Programs, McLean Fernside is a self-pay residential program providing unparalleled treatment in an unsurpassed setting. Our clinicians are experts in substance abuse recovery, rehabilitation and relapse prevention. They help to motivate individuals in their care to take the necessary steps to overcome addiction.
McLean Signature Recovery Programs: Fernside Reviews and Ratings Details
The following is based on a combination of Surveys of Alumni, Staff, Loved Ones, and Reviews and Ratings from around the web.
Reviews at a Glance
- Integrated Group Therapy (IGT)
Integrated Group Therapy is a psychotherapy tool that not only treats an individual for both disorders at the same time, but it addresses both of the disorders in singular sessions as though there is one condition. The integrated group therapy methods are similar to cognitive behavioral therapies in that group members share their experiences over the course of the previous week. Rather than speaking only to whether they had success or relapse in their drug use, they also focus on their mood swings and other issues that relate to both disorders.
- Dialectical Behavior Therapy (DBT)
Dialectical Behavior Therapy is a type of cognitive-behavioral psychotherapy developed in the late 1980s by psychologist Marsha M. Linehan to help better treat borderline personality disorder. Since its development, it has also been used for the treatment of other kinds of mental health disorders.
Rocco A. Iannucci, MD - Medical Director, Fernside, Instructor in Psychiatry, Harvard Medical School
Roger D. Weiss, MD - Chief, Division of Alcohol and Drug Abuse; Director, Alcohol and Drug Abuse Clinical Research Program, Professor of Psychiatry, Harvard Medical School
Dr. Weiss’ career has focused on treatment and clinical research with substance-dependent patients. He has received numerous NIH grants, developing integrated group therapy, an evidence-based treatment for co-occurring bipolar and substance use disorders, and leading a multi-site treatment study of prescription opioid dependence. He has authored over 300 publications, including several books, and was vice chair of the American Psychiatric Association Task Force on Practice Guidelines for Patients with Substance Use Disorders.
How Our Helpline Works
For those seeking addiction treatment for themselves or a loved one, the Recovery.org helpline is a private and convenient solution.
Calls to any general helpline (non-facility specific 1-8XX numbers) for your visit will be answered by American Addiction Centers (AAC).
We are standing by 24/7 to discuss your treatment options. Our representatives work solely for AAC and will discuss whether an AAC facility may be an option for you.
Our helpline is offered at no cost to you and with no obligation to enter into treatment. Neither Recovery.org nor AAC receives any commission or other fee that is dependent upon which treatment provider a visitor may ultimately choose.
For more information on AAC’s commitment to ethical marketing and treatment practices, or to learn more about how to select a treatment provider, visit our About AAC page.